{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:44:47Z","timestamp":1792082687213,"version":"4.4.0"},"reference-count":163,"publisher":"Elsevier","isbn-type":[{"value":"9780443192944","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.acc.2023.08.002","type":"book-chapter","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T04:07:15Z","timestamp":1695096435000},"page":"163-208","source":"Crossref","is-referenced-by-count":4,"title":["Immunohematological testing and transfusion management of the prenatal patient"],"prefix":"10.1016","author":[{"given":"NurJehan","family":"Quraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneeti","family":"Sapatnekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acc.2023.08.002_bib1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/vox.13361","article-title":"International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: update on blood group systems","volume":"117","author":"Gassner","year":"2022","journal-title":"Vox Sang."},{"issue":"Suppl.1","key":"10.1016\/bs.acc.2023.08.002_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1423-0410.2002.tb05321.x","article-title":"Alloimmunity to human red blood cell antigens","volume":"83","author":"Urbaniak","year":"2002","journal-title":"Vox Sang."},{"issue":"Suppl 1","key":"10.1016\/bs.acc.2023.08.002_bib3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1741-6892.2004.00488.x","article-title":"Adaptive immunity and transfusion","volume":"87","author":"Ouwehand","year":"2004","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/bjh.14175","article-title":"Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures","volume":"175","author":"Stack","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","article-title":"The development and consequences of red blood cell alloimmunization","volume":"18","author":"Arthur","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/bs.acc.2023.08.002_bib6","series-title":"Clinical Medicine, The Rh Blood Group System","first-page":"184","article-title":"Mollison\u2019s blood transfusion","author":"Klein","year":"2005"},{"key":"10.1016\/bs.acc.2023.08.002_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1537-2995.1990.30490273444.x","article-title":"Fetomaternal hemorrhage: incidence, occurrence, risk factors, time of occurrence, and clinical effects","volume":"30","author":"Sebring","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000491788","article-title":"The recurrence risk of fetomaternal hemorrhage","volume":"45","author":"Troia","year":"2019","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2023.08.002_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"De Haas","year":"2015","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus and newborn","author":"Delaney","year":"2015","journal-title":"Hematology: Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/bs.acc.2023.08.002_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/bs.acc.2023.08.002_bib12","series-title":"Rossi\u2019s Principle of Transfusion Medicine","first-page":"528","article-title":"Hemolytic disease of the fetus and newborn","author":"Solheim","year":"2016"},{"key":"10.1016\/bs.acc.2023.08.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102946","article-title":"Immunohematologic aspects of alloimmunization and alloantibody detection: a focus on pregnancy and hemolytic disease of the fetus and newborn","volume":"59","author":"Gupta","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cll.2020.10.009","article-title":"Hemolytic disease of the fetus and newborn. Historical and current state","volume":"41","author":"Jackson","year":"2021","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17474086.2022.2138853","article-title":"Identification and management of fetal anemia due to hemolytic disease","volume":"15","author":"Van\u2019T Oever","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0966-3274(02)00065-5","article-title":"Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn","volume":"10","author":"Hadley","year":"2002","journal-title":"Transpl. Immunol."},{"key":"10.1016\/bs.acc.2023.08.002_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1054\/blre.1999.0123","article-title":"RhD haemolytic disease of the fetus and the newborn","volume":"14","author":"Urbaniak","year":"2000","journal-title":"Blood Rev."},{"key":"10.1016\/bs.acc.2023.08.002_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/trf.14542","article-title":"Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody","volume":"58","author":"Phung","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/vox.13215","article-title":"Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: a retrospective cohort study","volume":"117","author":"Franchinard","year":"2022","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/bjh.17956","article-title":"Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine transfusion","volume":"196","author":"Vlachodimitropoulou","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21307\/immunohematology-2019-379","article-title":"Update on HDFN: new information on long-standing controversies","volume":"22","author":"Eder","year":"2006","journal-title":"Immunohematology"},{"key":"10.1016\/bs.acc.2023.08.002_bib22","series-title":"The Blood Group Antigen FactsBook","author":"Reid","year":"2012"},{"key":"10.1016\/bs.acc.2023.08.002_bib23","unstructured":"M.K. Fung, B.J. Grossman, C.D. Hillyer, C.M. Westhoff, AABB Technical Manual, 19th ed., AABB, Bethesda, MD, 2017."},{"key":"10.1016\/bs.acc.2023.08.002_bib24","first-page":"e82","article-title":"Management of alloimmunization during pregnancy","volume":"192","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ajcp\/aqaa120","article-title":"Implementation of a standardized prenatal testing protocol in an integrated, multihospital health system","volume":"155","author":"Sapatnekar","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2023.08.002_bib26","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1537-2995.2009.02233.x","article-title":"Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities","volume":"49","author":"Nordvall","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/tme.12661","article-title":"Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies","volume":"30","author":"Farrell","year":"2020","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102958","article-title":"Effect of multiple maternal red cell alloantibodies on the occurrence and severity of hemolytic disease of the fetus and newborn","volume":"60","author":"Singh","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib30","series-title":"Technical Manual","first-page":"659","article-title":"Perinatal issues in transfusion practice","author":"Lieberman","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib31","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/trf.14171","article-title":"Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk","volume":"57","author":"Li","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/trf.15154","article-title":"Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn","volume":"59","author":"Leonard","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/tme.12672","article-title":"Do red cell alloantibodies continue to challenge breast fed babies?","volume":"30","author":"Rasalam","year":"2020","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/trf.14446","article-title":"More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn","volume":"58","author":"Strauss","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/vox.13260","article-title":"Breast milk contains red cell isohaemagglutinins: doubts and dilemmas","volume":"117","author":"Datta","year":"2022","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib36","series-title":"Technical Manual","first-page":"297","article-title":"ABO and other carbohydrate blood group systems","author":"Olsson","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib37","first-page":"74","article-title":"ABO incompatibility in the newborn","volume":"32","author":"Kimball","year":"2018","journal-title":"J. Neonatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/vox.13327","article-title":"The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers","volume":"117","author":"Talwar","year":"2022","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPH.0000000000001248","article-title":"Severe ABO hemolytic disease of the newborn requiring exchange transfusion","volume":"41","author":"Metcalf","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/bs.acc.2023.08.002_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/ajts.AJTS_106_17","article-title":"Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion","volume":"12","author":"Jain","year":"2018","journal-title":"Asian J. Transfus. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41390-020-01232-5","article-title":"Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A\/anti-B IgG titer","volume":"90","author":"Krog","year":"2021","journal-title":"Pediatr. Res."},{"key":"10.1016\/bs.acc.2023.08.002_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/vox.13195","article-title":"ABO haemolytic disease of the newborn: improved prediction by novel integration of causative and protective factors in newborn and mother","volume":"117","author":"Krog","year":"2022","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/vox.13420","article-title":"Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn","volume":"108","author":"Krog","year":"2023","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib44","first-page":"e57","article-title":"Prevention of RhD alloimmunization","volume":"181","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib45","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1111\/trf.15569","article-title":"It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies","volume":"59","author":"Yazer","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib46","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib47","series-title":"Technical Manual","first-page":"355","article-title":"Other blood group systems and antigens","author":"Melland","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1537-2995.2003.00327.x","article-title":"Causes of fetal anemia in hemolytic disease due to anti-K","volume":"43","author":"Daniels","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib49","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/trf.17145","article-title":"RHD genotyping to resolve weak and discrepant RhD patient phenotypes","volume":"62","author":"Barriteau","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/trf.12995","article-title":"How do I manage Rh typing in obstetric patients?","volume":"55","author":"Haspel","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.14757","article-title":"Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype","volume":"179","author":"Sandler","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib52","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/trf.15741","article-title":"It\u2019s time to phase out \u201cserologic weak D phenotype\u201d and resolve D types with RHD genotyping including weak D type 4","volume":"60","author":"Flegel","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib53","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.78986","article-title":"What constitutes the most cautious approach for a pregnant person with weak D type 4.0?","volume":"193","author":"Flegel","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/bs.acc.2023.08.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102946","article-title":"Immunohematologic aspects of alloimmunization and alloantibody detection: a focus on pregnancy and hemolytic disease of the fetus and newborn","volume":"59","author":"Gupta","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib55","series-title":"Technical Manual","first-page":"389","article-title":"Identification of antibodies to red cell antigens","author":"Er","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Allard & British Committee for Standards in Haematology, Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib57","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia \u2013 \u2013 diagnosis and management","volume":"212","author":"Mari","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102947","article-title":"Non-invasive prenatal testing for management of hemolytic disease of the fetus and newborn induced by maternal alloimmunization","volume":"59","author":"Hyland","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib59","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/bs.acc.2023.08.002_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-019-2525-y","article-title":"Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital","volume":"19","author":"S\u00e1nchez-Dur\u00e1n","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/bs.acc.2023.08.002_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102877","article-title":"Noninvasive prenatal testing in immunohematology - clinical, technical and ethical considerations","author":"Kjeldsen-Kragh","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-2742-4","article-title":"Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review","volume":"20","author":"Runkel","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/bs.acc.2023.08.002_bib63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.22255","article-title":"Detection of fetomaternal hemorrhage","volume":"87","author":"Kim","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib64","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e3181da7929","article-title":"Fetomaternal hemorrhage","volume":"115","author":"Wylie","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.17352\/jgro.000021","article-title":"A case of severe, silent fetomaternal haemorrhage (FMH) detected by mixed-field in the mother\u2019s ABO typing","volume":"2","author":"Espinosa","year":"2016","journal-title":"J. Gynecol. Res. Obstet."},{"key":"10.1016\/bs.acc.2023.08.002_bib66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5858\/arpa.2021-0432-LE","article-title":"Assessment of flow cytometry and Kleihauer-Betke method when calculating fetomaternal hemorrhage and Rh immunoglobulin dose","volume":"146","author":"Gereg","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn \u2013 review on current management and outcome, Exp","volume":"10","author":"Zwiers","year":"2017","journal-title":"Rev. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib68","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/vox.12901","article-title":"Vox Sanguinis International Forum on the selection and preparation of blood components for intrauterine transfusion: summary","volume":"115","author":"Clarke","year":"2020","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib69","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/trf.17134","article-title":"Survey of intrauterine red blood cell (RBC) transfusion practices in the United States","volume":"62","author":"Bakhtary","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib70","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/trf.13020","article-title":"A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure","volume":"55","author":"Bontekoe","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib71","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical practice guidelines from the AABB, red blood cell transfusion thresholds and storage","volume":"316","author":"Carson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2023.08.002_bib72","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1537-2995.2004.04082.x","article-title":"Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17","volume":"44","author":"Denomme","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib73","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/trf.13231","article-title":"Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation","volume":"55","author":"Schonewille","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/tme.12145","article-title":"Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units","volume":"24","author":"Doyle","year":"2014","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib75","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1046\/j.1537-2995.1994.341195065035.x","article-title":"Induction of additional red cell alloantibodies after intrauterine transfusions","volume":"34","author":"Vi\u00ebtor","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2006-934092","article-title":"Prevalence of new maternal alloantibodies after intrauterine transfusion for severe rhesus disease","volume":"23","author":"Watson","year":"2006","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/tme.12437","article-title":"Transfusion-transmitted CMV infection \u2013 current knowledge and future perspectives","volume":"27","author":"Ziemann","year":"2017","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib78","series-title":"Technical Manual","first-page":"673","article-title":"Neonatal and pediatric transfusion practice","author":"Wong","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib79","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00383-013-3304-x","article-title":"Fetal surgical intervention: progress and perspectives","volume":"29","author":"Vrecenak","year":"2013","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/bs.acc.2023.08.002_bib80","unstructured":"Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Maternal-fetal Surgery for Myelomeningocele, ACOG Committee Opinion Number 720, September 2017, \u3008https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/09\/maternal-fetal-surgery-for-myelomeningocele\u3009, accessed 3\/13\/2023."},{"key":"10.1016\/bs.acc.2023.08.002_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100854","article-title":"Open and endoscopic fetal myelomeningocele surgeries display similar in-hospital safety profiles in a large, multi-institutional database","volume":"5","author":"Mikulski","year":"2023","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"10.1016\/bs.acc.2023.08.002_bib82","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/trf.16834","article-title":"Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development","volume":"62","author":"Hajjaj","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plabm.2015.10.001","article-title":"Comparison of the direct antiglobulin test and the eluate technique for diagnosing hemolytic disease of the fetus and newborn","volume":"13","author":"van Rossum","year":"2015","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pedneo.2014.11.005","article-title":"Importance of direct antiglobulin test (DAT) in cord blood: Causes of DAT (+) in a cohort study","volume":"56","author":"Valsami","year":"2015","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/archdischild-2013-305553","article-title":"How to use: the direct antiglobulin test in newborns","volume":"100","author":"Keir","year":"2015","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"10.1016\/bs.acc.2023.08.002_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/tme.12718","article-title":"Clinical implication of immunohaematological tests in ABO haemolytic disease of newborn: revisiting an old disease","volume":"31","author":"Das","year":"2021","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib87","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1055\/s-0035-1548538","article-title":"Predictive ability of direct antibody testing in infants born to mothers with Rh(D) and other minor red blood cell antibodies","volume":"32","author":"Ulrich","year":"2015","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib88","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41372-022-01556-6","article-title":"ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis","volume":"43","author":"Watchko","year":"2023","journal-title":"J. Perinatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib89","first-page":"140","article-title":"RhD blocking phenomenon implicated in an immunohaematological diagnostic dilemma in a case of RhD-haemolytic disease of the foetus","volume":"11","author":"Verma","year":"2013","journal-title":"Blood Transfus."},{"key":"10.1016\/bs.acc.2023.08.002_bib90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tmrv.2020.02.002","article-title":"Resolving blocked antigen phenomenon in hemolytic disease of the fetus and newborn due to anti-K","volume":"34","author":"Moosavi","year":"2020","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/bs.acc.2023.08.002_bib91","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ajh.23218","article-title":"The direct antiglobulin test: A critical step in the evaluation of hemolysis","volume":"87","author":"Zantek","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103177","article-title":"Is it necessary to add the eluate testing to the direct antiglobulin test to improve the detection of maternal erythrocyte alloantibodies?","volume":"60","author":"Toro Espinosa","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib93","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1111\/trf.12698","article-title":"Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D maternal RhIG","volume":"54","author":"Cohen","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib94","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/tme.12731","article-title":"Donor oocyte-facilitated reproduction: time to revisit the BSH antenatal guidelines?","volume":"30","author":"Quigley","year":"2020","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib95","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1537-2995.2003.00331.x","article-title":"Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes","volume":"43","author":"Patel","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib96","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1537-2995.2010.02883.x","article-title":"Don\u2019t ask, don\u2019t tell: the ART of silence can jeopardize assisted pregnancies","volume":"50","author":"Storry","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib97","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/j.1537-2995.2010.02698.x","article-title":"ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy","volume":"50","author":"Zuppa","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1537-2995.2003.00362.x","article-title":"HDN in a mother undergoing in vitro fertilization with donor ova","volume":"43","author":"Mair","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib99","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib100","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn cause by red blood cell antibodies undetected at first-trimester screening","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib101","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/trf.14156","article-title":"Anti-D in a mother, hemizygous for the variant RHD\u204eDNB gene, associated with hemolytic disease of the fetus and newborn","volume":"57","author":"Quantock","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-3148.2007.00816.x","article-title":"Haemolytic disease of the newborn presenting in a term baby born to a mother with negative red cell serology screening","volume":"18","author":"Joshi","year":"2008","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib103","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2019.07.014","article-title":"Coordinating care across the perinatal continuum in hemolytic disease of the fetus and newborn: the timely handoff of a positive maternal anti-erythrocyte antibody screen","volume":"214","author":"Vats","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.acc.2023.08.002_bib104","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1471-0528.13816","article-title":"Third trimester screening for alloimmunization in Rhc-negative pregnant women: evaluation of the Dutch national screening programme","volume":"123","author":"Slootweg","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/bs.acc.2023.08.002_bib105","series-title":"Technical Manual","first-page":"116","article-title":"Methods and appendices. Method 5-3, using antibody titration studies to assist in early detection of hemolytic disease of the fetus and newborn","year":"2020"},{"key":"10.1016\/bs.acc.2023.08.002_bib106","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/trf.15631","article-title":"Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K alloimmunized pregnancies","volume":"60","author":"Koelewijn","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib107","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/trf.16388","article-title":"Comparison of prenatal anti-D titration testing by gel and tube methods: a review of the literature","volume":"61","author":"Lieberman","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib108","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib109","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy","volume":"109","author":"van Wamelen","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.07.020","article-title":"Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management","volume":"219","author":"Slootweg","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib111","first-page":"18","article-title":"Rising antenatal anti-K titres despite a K-negative foetus","volume":"31","author":"Khwaja","year":"2021","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib112","first-page":"667","article-title":"Management of pregnancies complicated by anti-Kell isoimmunization","volume":"93","author":"McKenna","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib113","series-title":"Human Blood Groups","first-page":"99","article-title":"MNS blood group system","author":"Daniels","year":"2002"},{"key":"10.1016\/bs.acc.2023.08.002_bib114","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M alloimmunization: management and outcome at a single institution","volume":"7","author":"Stetson","year":"2017","journal-title":"Am. J. Perinatol. Rep."},{"key":"10.1016\/bs.acc.2023.08.002_bib115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1537-2995.2007.01209.x","article-title":"Fetal hemolytic anemia and intrauterine death caused by anti-M immunization","volume":"47","author":"Wikman","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/bs.acc.2023.08.002_bib117","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/trf.15578","article-title":"Cold reacting anti-M causing delayed hemolytic disease of the newborn","volume":"59","author":"Crispin","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib118","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/trf.15054","article-title":"Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature","volume":"59","author":"Li","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib119","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/trf.16252","article-title":"Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures","volume":"61","author":"Andersen","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib120","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/trf.16350","article-title":"Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus","volume":"61","author":"Li","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102949","article-title":"Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M and anti-Jra cases","volume":"59","author":"Ohto","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib122","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tjog.2017.04.022","article-title":"Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions","volume":"56","author":"Li","year":"2017","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib123","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1537-2995.2007.01401.x","article-title":"Molecular genotyping for RHD: what (not) to do?","volume":"47","author":"Westhoff","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib124","first-page":"528","article-title":"Relationship between previous maternal transfusions and haemolytic disease of the foetus and newborn mediated by non-RhD antibodies","volume":"11","author":"Dajak","year":"2013","journal-title":"Blood Transfus."},{"key":"10.1016\/bs.acc.2023.08.002_bib125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.17201","article-title":"KEL1 negative red cell transfusions for females of current or future child-bearing potential: a clinical impact and feasibility study","volume":"63","author":"Ning","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib126","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/trf.13977","article-title":"Blood group Antigen Matching Influence on Gestational Outcomes (AMIGO) study","volume":"57","author":"Delaney","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib127","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/trf.12814","article-title":"Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review","volume":"55","author":"O\u2019Brien","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib128","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/trf.16276","article-title":"Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: a nation-wide policy change evaluation study in the Netherlands","volume":"61","author":"Luken","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24323","article-title":"Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG","volume":"36","author":"Walhof","year":"2022","journal-title":"J. Lab. Clin. Anal."},{"key":"10.1016\/bs.acc.2023.08.002_bib130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/tme.12420","article-title":"Can serological methods help distinguish between prophylactic and alloimmune anti-D?","volume":"27","author":"Irving","year":"2017","journal-title":"Transfus. Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/vox.12302","article-title":"Interpretation of pretransfusion testing in obstetric patients who have received antepartum Rh immunoglobulin prophylaxis","volume":"110","author":"Szkotak","year":"2016","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib132","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1537-2995.1997.37597293879.x","article-title":"Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies","volume":"37","author":"Shirey","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib133","doi-asserted-by":"crossref","first-page":"166","DOI":"10.21307\/immunohematology-2019-376","article-title":"Case report: moderate hemolytic disease of the newborn due to anti-G","volume":"22","author":"Huber","year":"2006","journal-title":"Immunohematology"},{"key":"10.1016\/bs.acc.2023.08.002_bib134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21307\/immunohematology-2019-124","article-title":"Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions","volume":"29","author":"Strindberg","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/bs.acc.2023.08.002_bib135","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/trf.13806","article-title":"Autologous intrauterine transfusion in a case of anti-U","volume":"56","author":"Adam","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib136","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/trf.17204","article-title":"Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti-U: a case report","volume":"63","author":"Badawi","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib137","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2007-992176","article-title":"Severe intrauterine hemolysis due to anti-Cw","volume":"24","author":"Chu","year":"2007","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib138","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-934098","article-title":"Severe neonatal hemolysis due to a maternal antibody to the low-frequency Rh antigen Cw","volume":"23","author":"May-Wewers","year":"2006","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/bs.acc.2023.08.002_bib139","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2009.03.013","article-title":"Antibodies to low-incidence antigens","volume":"40","author":"Coghlan","year":"2009","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/bs.acc.2023.08.002_bib140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1891\/0730-0832.31.2.69","article-title":"Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature","volume":"31","author":"Squires","year":"2012","journal-title":"Neonatal Netw."},{"key":"10.1016\/bs.acc.2023.08.002_bib141","first-page":"32","article-title":"Hemolytic disease of the fetus and newborn mediated by anti-Dia in a U.S. hospital","volume":"39","author":"Jacobs","year":"2023","journal-title":"Immunohematology"},{"key":"10.1016\/bs.acc.2023.08.002_bib142","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1046\/j.1537-2995.2001.41121559.x","article-title":"Increased RBC autoantibody production in pregnancy","volume":"41","author":"Hoppe","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib143","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000440672","article-title":"Harmless pregnancy-induced warm autoantibodies to red blood cells","volume":"42","author":"S\u00fcr\u00fcc\u00fc","year":"2015","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/bs.acc.2023.08.002_bib144","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood.2022018890","article-title":"Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience","volume":"141","author":"Fattizzo","year":"2023","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2023.08.002_bib145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1423-0410.1982.tb00008.x","article-title":"Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy","volume":"43","author":"Sokol","year":"1982","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib146","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1080\/14767058.2017.1349746","article-title":"Anemia and pregnancy outcomes: a longitudinal study","volume":"31","author":"Tunkyi","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib147","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s002770100357","article-title":"Pregnancy induced hemolytic anemia: an unexplained entity","volume":"80","author":"Kumar","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib148","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14740\/jh171w","article-title":"Idiopathic hemolytic anemia of pregnancy: a diagnostic dilemma","volume":"3","author":"Gupta","year":"2014","journal-title":"J. Hematol."},{"key":"10.1016\/bs.acc.2023.08.002_bib149","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1067\/mob.2000.106132","article-title":"Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery","volume":"182","author":"Naylor","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9378(99)70443-6","article-title":"Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetrics and gynecologic procedures","volume":"181","author":"Garratty","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2023.08.002_bib151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21307\/immunohematology-2019-335","article-title":"Warm autoantibody or drug-dependent antibody? That is the question!","volume":"23","author":"Johnson","year":"2007","journal-title":"Immunohematology"},{"key":"10.1016\/bs.acc.2023.08.002_bib152","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14767050600631757","article-title":"Autoimmune hemolytic anemia caused by cold agglutinins in a young pregnant woman","volume":"19","author":"Batalias","year":"2006","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib153","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/14767058.2020.1732344","article-title":"Autoimmune hemolytic anemia in pregnancy: a challenge for maternal and fetal follow-up","volume":"35","author":"Maroto","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22274","article-title":"Defining the clinical relevance of red cell autoantibodies by monocyte monolayer assay","volume":"32","author":"Conrado","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/bs.acc.2023.08.002_bib155","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.3324\/haematol.2017.177675","article-title":"Clinical relevance of silent red blood cell autoantibodies","volume":"102","author":"Mauro","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/bs.acc.2023.08.002_bib156","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1537-2995.2008.01736.x","article-title":"Antibody identification using both automated solid-phase red cell adherence assay and a tube polyethylene glycol antiglobulin method","volume":"48","author":"Yamada","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib157","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/trf.14079","article-title":"Patient factors associated with unidentified reactivity in solid-phase and polyethylene glycol antibody detection methods","volume":"57","author":"Miller","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib158","first-page":"136A","article-title":"Investigation of apparent solid phase-only red cell serologic reactivity: clinical and laboratory correlations","volume":"62","author":"Blackall","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib159","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.3109\/14767058.2015.1107540","article-title":"Non-specific red cell reactivity in an obstetric population","volume":"29","author":"Van Winden","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2023.08.002_bib160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/trf.17276","article-title":"Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: the BEST collaborative study","volume":"63","author":"Lu","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib161","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/vox.12797","article-title":"Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity","volume":"114","author":"Conrado","year":"2019","journal-title":"Vox Sang."},{"key":"10.1016\/bs.acc.2023.08.002_bib162","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.12070","article-title":"Antibody of undetermined specificity: frequency, laboratory features, and natural history","volume":"53","author":"Liu","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/bs.acc.2023.08.002_bib163","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242323000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242323000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T12:55:31Z","timestamp":1704286531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242323000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443192944"],"references-count":163,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2023.08.002","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}